Richard M Ransohoff. Show Affiliations »
Abstract
Entities: Chemical Gene
Mesh: See more » AnimalsAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedHumansLeukoencephalopathy, Progressive Multifocal/chemically inducedLeukoencephalopathy, Progressive Multifocal/diagnosisLeukoencephalopathy, Progressive Multifocal/immunologyMultiple Sclerosis/drug therapyMultiple Sclerosis/immunologyNatalizumabRisk Factors
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedNatalizumab
Year: 2010 PMID: 20117056 DOI: 10.1016/S1474-4422(10)70025-9
Source DB: PubMed Journal: Lancet Neurol ISSN: 1474-4422 Impact factor: 44.182